김순선 (아주대학교 의과대학)님 | 한빛사연구자 > 한빛사

아주대학교 의과대학

CV File

최종업데이트 2025.12.24.

[Correspondence] Response to the Editorial on "Bacteroides eggerthii: a New Human Gut Probiotic Against Metabolic Dysfunction-Associated Steatotic Liver Disease"
- Clin. Mol. Hepatol., Dec 23 2025, | https://doi.org/10.3350/cmh.2025.1416
- 2025-12
- 의약학
- 한빛사논문
Bacteroides eggerthii Ameliorates MASLD through Host-Microbe Signaling and Highlights 2-Hydroxyisocaproate as a Potential Effector
- Clin. Mol. Hepatol., Oct 27 2025, | https://doi.org/10.3350/cmh.2025.0475
- 2025-10
- 의약학
- 한빛사논문
[Correspondence] Response to Editorial on "GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC"
- Clin. Mol. Hepatol., Apr 04 2025, | https://doi.org/10.3350/cmh.2025.0350
- 2025-04
- 의약학
- 한빛사논문
[Editorial] The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on "The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study"
- Clin. Mol. Hepatol., Jan 2025, 31 (1) | https://doi.org/10.3350/cmh.2024.0847
- 2025-01
- 의약학
- 한빛사논문
Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma
- J. Exp. Clin. Cancer Res., Published: 30 October 2023 | https://doi.org/10.1186/s13046-023-02867-y
- 2023-10
- 의약학
- 한빛사논문
Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma
- J. Exp. Clin. Cancer Res., Published 28 April 2022 | https://doi.org/10.1186/s13046-022-02365-7
- 2022-04
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기